GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
African storytellers, not outsiders, should tell Africa’s story in cinema, South African filmmaker Mehret Mandefro has told RT...
Haile Cummings, 34, was allegedly part of the crew involved in the deadly shootout with rival gang members at the Taste of the City Lounge in Crown Heights in the early hours of Aug. 17, according to ...
US attorney for Washington, DC, Jeanine Pirro said the US would never stop seeking justice for Americans killed by terrorists after the arrest of Zubayr Al-Bakoush, who is alleged to be one of the lea...
